Organization
Sunnybrook Odette Cancer Centre
9 abstracts
Abstract
Systemic treatments in favorable and very favorable risk metastatic renal cell carcinoma (mRCC): Real world evidence from the International mRCC Database Consortium (IMDC).Org: Alberta, Canada, Sunnybrook Odette Cancer Centre,
Abstract
Impact of geography on receipt of medical oncology consultation and neoadjuvant chemotherapy for triple negative and HER2 positive breast cancer.Org: University of Toronto, Odette Cancer Centre, Sunnybrook Health Sciences Centre, ICES, Sunnybrook Odette Cancer Centre,
Abstract
TACTIVE-U: Phase 1b/2 umbrella study of ARV-471, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, combined with other anticancer treatments in ER+ advanced or metastatic breast cancer.Org: University of Texas MD Anderson Cancer Center, Sunnybrook Odette Cancer Centre, University of Toronto, The Ottawa Hospital and University of Ottawa, Washington University School of Medicine in St Louis,
Abstract
HER2-low breast cancer brain metastases: Incidence and treatment implications.Org: University of Toronto, Sunnybrook Hospital, Toronto, ON, Canada, Sunnybrook Health Sciences Center, Department of Laboratory Medicine and Pathobiology,
Abstract
Characterizing progression to subsequent lines of therapy in metastatic renal cell carcinoma (mRCC) after nivolumab plus ipilimumab (Nivo+Ipi): Results from the International mRCC Database Consortium (IMDC).Org: Tom Baker Cancer Centre, University of Calgary, BC Cancer Agency Vancouver Island Centre, University Hospital of Southern Denmark, University of Bari 'A. Moro',
Abstract
CCTG HN11: SPECT-CT guided elective contralateral neck treatment (SELECT) for patients with lateralized oropharyngeal cancer—A phase III randomized controlled trial.Org: University Health Network, Canadian Cancer Trials Group, CHUM - Centre Hospitalier de l'Universite de Montreal, Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), University of Toronto,
Abstract
Brain metastasis burden and management in small cell lung cancer: An analysis of 8705 patients.Org: University of Toronto, Princess Margaret Cancer Centre, Sunnybrook Odette Cancer Centre, University Health Network, St. Michael's Hospital and University of Toronto,
Abstract
Efficacy and safety study of a novel alpha-fetoprotein (AFP)-maytansine conjugate in an ovarian xenograft model.Org: Alpha Cancer Technologies Inc, Sunnybrook Research Institute, Southern Research Institute, Sunnybrook Odette Cancer Centre,
Abstract
Prophylactic cranial irradiation in small cell lung cancer patients in the era of magnetic resonance imaging: A systematic review and meta-analysis.Org: University of Toronto, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Princess Margaret Cancer Centre, University Health Network,